ARCHIVES

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | March 24, 2006

Download PDF Visit The Full Archive

Related Articles

Moloney Out As Viral Oncology Chief, Names “Acting Assistant Director” Of NCI By Upton

January 6, 1978

Concepts For Computer Support Services Ok’d By NCAB Committee

September 25, 1992

Clinical Practice Guidelines Don’t Meet IOM Standards

June 26, 2013

NCI, NSABP Launch Taxifin Trial For Prevention Of Breast Cancer

May 8, 1992

In Brief: Moloney, Manaher, 11 Other NCI Staff Members Retire; Terry Takes Leave From Immunology Jobs

March 7, 1980

Cancer Documentary Provides Argument for Increased Funding

May 23, 1986